Biomind Labs Inc.
BMNDF
$0.70
$0.3924127.57%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 83.73% | -13.91% | 31.57% | -116.64% | 65.22% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -- | -100.00% | -73.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -154.49% | 37.09% | -50.69% | 5,203.33% | -287.50% |
| Change in Net Operating Assets | -127.59% | 1,260.00% | 92.32% | -820.20% | -105.28% |
| Cash from Operations | -340.87% | 78.16% | 45.07% | -54.15% | 16.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -28.09% | -13.10% | -15.60% | -53.74% | 43.93% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -34.66% | -13.10% | -16.39% | -53.30% | 45.02% |
| Foreign Exchange rate Adjustments | 276.42% | -643.59% | 360.00% | 93.83% | -145.85% |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -- | -- | -- |
| Net Change in Cash | -73.68% | -159.64% | 121.30% | -253.74% | 45.51% |